Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

Summary

Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy

Timeline

Start

2021-02-01

Primary completion

2024-05-15

Completion

2024-05-15

Outcome

Outcome not reported

Stopped (Business): “The early termination of this study is a business decision following a portfolio reprioritization plan. The decision is not related to any Efficacy, Safety or Clinical concerns regarding Nomacopan/rVA576”

Drugs

Indications